Drug Treatment for Chronic Cystitis
For chronic cystitis, nitrofurantoin (100 mg twice daily for 5-7 days) is recommended as first-line therapy, with trimethoprim-sulfamethoxazole and fosfomycin as alternatives when local resistance patterns are favorable. 1
First-Line Treatment Options
Nitrofurantoin
- Dosage: 100 mg twice daily for 5-7 days
- Advantages: Effective against most common uropathogens
- Contraindications:
- Avoid in renal impairment (GFR <30 ml/min)
- Avoid in third trimester of pregnancy
- Not recommended for infants under 4 months due to risk of hemolytic anemia 1
Trimethoprim-Sulfamethoxazole (TMP-SMX)
- Dosage: 1 double-strength tablet (800 mg/160 mg) every 12 hours for 10-14 days 2
- Only recommended when local resistance rates are <20% (clinical cure rates drop significantly with resistant organisms) 1
- Adjust dosage in renal impairment:
- CrCl 30-50 mL/min: Standard dose
- CrCl 15-30 mL/min: Half the usual regimen
- CrCl <15 mL/min: Not recommended 2
Fosfomycin
- Dosage: 3 g single dose
- Good option for uncomplicated cystitis 1
- Particularly useful when antibiotic resistance is a concern 3
Second-Line Treatment Options
Fluoroquinolones (e.g., Ciprofloxacin)
- Dosage: 500 mg twice daily for 7-14 days 4
- Particularly effective for complicated UTIs when local fluoroquinolone resistance is <10% 1
- Should be reserved as second-line agents due to resistance concerns and adverse effects 3
- Avoid as first-line agents in elderly patients due to increased risk of adverse effects 1
Cephalosporins
- Cefalexin 500 mg four times daily for 7-14 days (14 days for men when prostatitis cannot be excluded) 1
- Recommended for complicated UTIs or when other options aren't suitable
Special Considerations
Duration of Treatment
- Uncomplicated cystitis: 3-7 days
- Complicated cystitis: 7-14 days 1
Patient-Specific Factors
Pregnant Women:
- Nitrofurantoin 100 mg twice daily for 5-7 days (if normal renal function)
- Avoid nitrofurantoin in third trimester
- Cephalosporins (e.g., cefuroxime) are safe alternatives 3
Patients with Renal Impairment:
- Avoid nitrofurantoin if GFR <30 ml/min
- Adjust TMP-SMX dosage according to creatinine clearance 2
Hemodialysis Patients:
- TMP-SMX at half the standard dose (one single-strength tablet daily or one double-strength tablet three times weekly) administered after each dialysis session 1
Elderly Patients:
- Avoid fluoroquinolones as first-line therapy
- Consider increased fluid intake (additional 1.5L daily) to help prevent recurrence 1
Management of Recurrent Cystitis
For patients experiencing recurrent cystitis (≥3 episodes/year or ≥2 episodes in 6 months) 3:
Self-initiated therapy:
- Short course of antibiotics at first sign of symptoms
- This approach minimizes overall antibiotic exposure 5
Prophylactic options:
Important Caveats
- Local antimicrobial susceptibility patterns should guide empiric therapy choices 1
- Evaluate clinical response within 48-72 hours of initiating therapy 1
- Follow-up urine culture should be performed 7 days after completing treatment 1
- Interstitial cystitis, though presenting with similar symptoms, is not bacterial in nature and does not respond to antibiotics 6
- Asymptomatic bacteriuria should not be treated in elderly patients as this increases antibiotic resistance without clinical benefit 1